As we enter a new era of #MultipleSclerosis research focused on halting disease progression, Luis Felipe Orozco and Dr. Jiwon Oh discuss how smoldering neuroinflammation manifests in patients. 🧠✨ Learn about our continued commitment to delivering innovative solutions to help address the needs of people living with MS🌍🔬: http://spkl.io/6042f1K96 #ECTRIMS2024
Sanofi
Fabrication de produits pharmaceutiques
Paris, France 4 105 604 abonnés
À propos
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms
- Seite web
-
http://www.sanofi.com
Lien externe pour Sanofi
- Secteur
- Fabrication de produits pharmaceutiques
- Größe des Unternehmens
- + de 10 000 Beschäftigte
- Siège social
- Paris, Frankreich
- Typ
- Börsennotierte Gesellschaft
- Domains
- vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases et consumer healthcare
Lieux
Employés chez Sanofi
Nouvelles
-
This summer, the #MeningitisFlag spent time in Paris, enjoying the excitement of the #Paris2024 Games and spreading awareness about #meningitis. The Meningitis Flag shared its Photo Dump with us: 1. The perfect combo: a Paris 2024 volunteer, the Phryge, the Eiffel Tower and me 💛💜💙 2. Reading the Paris 2024 Official Programme in the Jardin des Tuileries 3. Met some amazing volunteers and traded pins 4. Mum, I’m on the metro! 🫣 5. Found the best team to cheer on Ellie Challis 🥇 6. Admiring the Pont Alexandre III and the beauty of Paris ❤️
-
We did it the French way. ✨ The Revolution ignited a shift. Whether in sports or in science, we unite our strength in the pursuit of innovation. #WeNeverSettle #IgnitingPotential #Paris2024
-
¡Vivimos la Misión Paciente en la VIII edición del Seminario de Gestión del Riesgo en Salud! Nos reunimos en Cartagena con más de 160 líderes del sector salud del país para analizar y co-crear estrategias que ayuden a mejorar la experiencia de atención del paciente y derribar barreras a la innovación desde un enfoque sostenible. Gracias a todos los participantes y conferencistas por generar conversaciones de valor que impulsan el bienestar de los pacientes y permiten alcanzar resultados en salud óptimos para todos los colombianos. ¡Nos vemos en 2025 con una nueva edición de nuestro Seminario! #MisiónPaciente #GestiónDelRiesgo #Innovación #AccesoALaSalud
-
Ahead of #ESMO24, we are excited to announce an exclusive licensing agreement with Orano Med and Radiomedix, Inc. to advance a next-generation medicine, currently in Phase 2, in the expanding field of radioligand therapies (RLTs). RLTs represent an emerging area of oncology research being explored in a number of solid tumors. This includes neuroendocrine tumors (NETs), a heterogeneous group of rare cancers that originate from neuroendocrine cells, where there is a significant unmet need for new therapies. Read our press release: https://lnkd.in/emWuaFsd
-
Phase 3 data shows positive results for our investigational medicine in patients aged 6 years and older with chronic spontaneous urticaria (CSU). These data demonstrate the potential for a new treatment option for people who remain uncontrolled on standard of care. Read more about the news: https://lnkd.in/eNKPC-Rc Regeneron
-
Pivotal data demonstrate the potential for our investigational treatment in adults with bullous pemphigoid, which would help address a significant unmet medical need for people with this chronic and relapsing skin disease. Read more about the news: https://lnkd.in/evs8947R Regeneron
-
THANK YOU to our 2,024 volunteers for making the #Paris2024 Olympic & Paralympic Games unforgettable! 💜 The Games were all about passion, dedication, and vibrant connections for our Sanofians. So many memories of this once-in-a-lifetime event they’ll treasure forever. ✨ We couldn’t be prouder of our volunteers and the incredible work they’ve done to turn the Games into a dream come true for everyone. 🤩 #IgnitingPotential #WeNeverSettle #Paris2024 #Olympics #Paralympics Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024
-
Merci Paris 2024 ✨ Merci Team Sanofi 💜 Merci Sanofi Volunteers 🫶 What an unforgettable experience these Games have been! We showed the world how science and sport are so closely connected. It’s all about the determination and resilience that bring us together. 💜 #WeNeverSettle #IgnitingPotential #TeamSanofi #Paris2024 #Paralympics Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024
-
👉 We’re taking you through the streets of Paris during the #Paris2024 Paralympic Games, zooming in on the #MeningitisFlag campaign displayed at the Franklin D. Roosevelt metro station. With the Games lighting up Paris, this is an experience in its own right: one dedicated to the fight against meningitis, featuring para-athletes Ellie Challis, Theo Curin, and Davide Morana proudly flying the #MeningitisFlag. 💛💜💙 Participate from where you stand and click here to raise their score: http://spkl.io/6041fBtbD #DefeatMeningitis #ParalympicGames Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024 Meningitis Research Foundation
Angegliederte Seiten
Ähnliche Seiten
Parcourir les offres d'emploi
Financement
Dernier round
Capital après introduction en Bourse329 024 935,00 $US
Investisseurs
Blackstone Life Sciences